[MFLOUR] QoQ Annualized Quarter Result on 30-Sep-2022 [#3]

Stock
[MFLOUR] MALAYAN FLOUR MILLS BHD
Announcement Date
21-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- 25.95%
YoY- -34.5%
Quarter Report
Latest QR
Upcoming QR
MFLOUR's Result
MFLOUR's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 3,158,886 3,306,776 2,915,570 2,794,674 2,593,106 2,539,508 2,426,936 19.26%
PBT 20,622 61,664 179,444 170,578 150,012 134,096 96,904 -64.45%
Tax -3,312 -10,080 -25,444 -24,612 -25,820 -29,844 101,638 -
NP 17,310 51,584 154,000 145,966 124,192 104,252 198,542 -80.42%
-
NP to SH 16,950 41,760 145,045 130,894 103,924 81,264 173,909 -78.91%
-
Tax Rate 16.06% 16.35% 14.18% 14.43% 17.21% 22.26% -104.89% -
Total Cost 3,141,576 3,255,192 2,761,570 2,648,708 2,468,914 2,435,256 2,228,394 25.80%
-
Net Worth 1,399,038 1,367,478 1,366,963 1,346,336 1,305,475 1,254,251 1,254,173 7.58%
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div 30,635 - 30,603 20,399 30,597 - 20,393 31.26%
Div Payout % 180.74% - 21.10% 15.58% 29.44% - 11.73% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth 1,399,038 1,367,478 1,366,963 1,346,336 1,305,475 1,254,251 1,254,173 7.58%
NOSH 1,021,250 1,020,981 1,020,210 1,020,089 1,019,903 1,019,903 1,019,653 0.10%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.55% 1.56% 5.28% 5.22% 4.79% 4.11% 8.18% -
ROE 1.21% 3.05% 10.61% 9.72% 7.96% 6.48% 13.87% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 309.33 324.03 285.81 274.00 254.25 249.04 238.02 19.14%
EPS 1.66 4.08 14.22 12.84 10.20 7.96 17.08 -78.95%
DPS 3.00 0.00 3.00 2.00 3.00 0.00 2.00 31.13%
NAPS 1.37 1.34 1.34 1.32 1.28 1.23 1.23 7.47%
Adjusted Per Share Value based on latest NOSH - 1,020,089
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 254.92 266.86 235.29 225.53 209.26 204.94 195.85 19.26%
EPS 1.37 3.37 11.71 10.56 8.39 6.56 14.03 -78.88%
DPS 2.47 0.00 2.47 1.65 2.47 0.00 1.65 30.95%
NAPS 1.129 1.1036 1.1031 1.0865 1.0535 1.0122 1.0121 7.58%
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 0.60 0.765 0.76 0.565 0.62 0.625 0.685 -
P/RPS 0.19 0.24 0.27 0.21 0.24 0.25 0.29 -24.62%
P/EPS 36.15 18.69 5.35 4.40 6.08 7.84 4.02 334.17%
EY 2.77 5.35 18.71 22.71 16.43 12.75 24.90 -76.96%
DY 5.00 0.00 3.95 3.54 4.84 0.00 2.92 43.26%
P/NAPS 0.44 0.57 0.57 0.43 0.48 0.51 0.56 -14.88%
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/08/23 18/05/23 27/02/23 21/11/22 25/08/22 27/05/22 28/02/22 -
Price 0.635 0.75 0.815 0.61 0.575 0.635 0.625 -
P/RPS 0.21 0.23 0.29 0.22 0.23 0.25 0.26 -13.30%
P/EPS 38.26 18.33 5.73 4.75 5.64 7.97 3.66 380.14%
EY 2.61 5.46 17.45 21.04 17.72 12.55 27.29 -79.17%
DY 4.72 0.00 3.68 3.28 5.22 0.00 3.20 29.66%
P/NAPS 0.46 0.56 0.61 0.46 0.45 0.52 0.51 -6.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment